The global plasma products market has more than doubled since 2000 as a result of an increase in demand and prices of plasma products. The worldwide plasma supply has increased but not at the same rate as the demand for the plasma products. The global plasma products market has been segmented on the basis of plasma proteins like immunoglobulin, albumin, clotting factors, and other proteins. The IVIG or Immunoglobulin market is the largest segment of the plasma products market, making up more than fifty percent share of the market. The IVIG and Albumin segments have been the real drivers of the global plasma products market as they witnessed double-digit growth rates over the last few years.

The global blood plasma products market has undergone drastic changes. From the early days when plasma products were considered unsafe and a threat to spreading of diseases like HIV, global blood plasma now helps save lives and treats bleeding disorders, all assisting people with leading normal lives.

The US is the largest market for plasma products consumption, according to Reuters as well as in terms of supply of human plasma. More than fifty percent of global plasma supply comes from the US. The US regulation which allows companies to pay the donor of plasma has significantly contributed toward the high supply of plasma from the US.

Among the emerging markets, China is the most potential target market for plasma products. The market has grown significantly over the last few years. The changes in the Chinese plasma product market have significantly contributed toward the global mismatch of demand and supply of plasma and plasma products.

Image Credit: